(Jeff Whyte/Shutterstock) |
|
|
Amazon had… an unusual day. First, news emerged that Amazon would list tariff costs next to prices on its site (as Temu is already doing), leading the White House to call the move a “hostile and political act” in a morning press conference. Then Amazon said, no no no, we were only thinking about doing that on Amazon Haul! But the story first started because of a post on Punchbowl that appears to be sponsored by, you guessed it, Amazon. Looking forward to listening to its earnings call tomorrow!
The S&P 500 gained for its sixth consecutive day, the longest such streak since September, as investors cheered a slate of mostly positive corporate earnings — even as companies were skittish to provide details on their outlooks — and welcomed fresh tariff relief on autos. The Nasdaq 100 even briefly erased all of its losses since the April 2 close, just before reciprocal tariffs were announced in the Rose Garden..
|
|
|
Royal Caribbean’s earnings yesterday showed a company defiant to the economic burdens that has the rest of the business world hedging bets, yanking guidance, and dialing back expectations.
We’ve seen company after company stare down a volatile trade situation and an American consumer whose financial security has been checked over the past several weeks, and what have we seen? Adjusted guidance, and not in a good direction. |
Royal Caribbean scoffs at this! Based on what it’s seeing, the American consumer will spend their bottom dollar if that’s what it takes to get on a cruise ship this year. Bookings are on track, cancellation levels are normal, and close-in demand is great, the company says. Lower guidance? To Davy Jones’ Locker, go ye!
No, Royal Caribbean saw the world for what it is and made the assessment that demand for frozen drinks in pools floating in the Caribbean will be existentially necessary to huge swaths of the American populace. |
|
|
Damn the torpedoes and full speed ahead — Royal Caribbean raised guidance, now anticipating full-year earnings per share between $14.55 and $15.55, up from its prior forecast of $14.35 to $14.65. |
|
|
Not Funded by Big Pharma. Not Distracted by Wall Street.
|
Most biotech startups chase venture dollars or Big Pharma buyouts. Not Cytonics.
Big Pharma has failed to deliver a disease-modifying therapy for osteoarthritis (DMOAD) — but Cytonics refuses to accept that. By genetically enhancing a naturally occurring blood protein called A2M, they've created CYT-108 — a groundbreaking biologic poised to become the first true disease-modifying therapy for osteoarthritis.
Cytonics has raised exactly $0.00 from venture capital giants and is funding the development of CYT-108 from everyday investors — and now, they’re preparing to enter a pivotal Phase 2 trial
Science this promising shouldn’t be reserved for venture funds. Now it isn’t. Join the movement to democratize biotech innovation1 → |
|
|
Tariff exemption is coming for automakers, or at least for their vehicles made from 85% US content. For a year, cars that are made with at least 85% domestic and USMCA-compliant content will be able to apply for full reimbursement from tariffs, according to a Wall Street Journal report that cited a senior US official. After a year, that percentage goes up to 90%.
Sounds great! That must be a lot of cars, right? Lots of American automakers are sure to benefit, right? Well… |
- None of the big three automakers are anywhere close. As of last year, the average US content for Ford vehicles was 54%, tied with GM. Each of them is well above the 46% American content at Stellantis, which makes Jeep and Dodge.
-
Honda is the closest to the mark for major automakers, with 63% average US content for its vehicles, well above fellow Japanese automakers with major American presences Toyota (29%) and Nissan (24%).
- At Tesla, the company owned largely by Elon Musk, a close confidant to the man instrumental in developing and executing administration policy, that figure is 81%.
|
|
|
Tariffs have thrown a spanner in the works for automakers, which are major manufacturing employers. Just yesterday, GM had to postpone its investor call following claims of possible tariff relief. Realistically, it’s incredibly hard to operate with this much uncertainty, and it’s this exact kind of company that serves as the flagship of the US industrial base.
|
|
|
Invest Beyond the News Cycle |
|
|
|
